Because there has been no quality improvement initiatives targeting patients with type 2 diabetes (T2D) receiving basal insulin therapy, this study evaluated the effectiveness of physician‐targeted education for optimizing glycemic management in these patients in China. The gene discussed is INS; the disease is type 2 diabetes mellitus.